For pharmaceutical companies searching for the right development and manufacturing partner, CPHI is one of the most important opportunities of the year to have meaningful conversations with the experts who can move programs forward. This year in Milan, Contract Pharmaceuticals Limited (CPL) is arriving with an expanded presence, a refreshed brand, a growing team, and an important message for companies developing and commercializing complex dosage forms: you may be surprised by just how much CPL can do.
CPHI has long been an important meeting for CPL. Unlike conferences centered primarily on academic research or scientific presentations, CPHI brings together pharmaceutical companies, suppliers, development organizations, manufacturers, and decision-makers with a clear focus on partnerships and outsourcing. It creates an environment where conversations quickly move from introductions to real programs, real challenges, and real opportunities.
For CPL, that makes Milan an ideal place to reconnect with existing customers, establish new relationships, and introduce the industry to the CPL of today.
A New Look at CPL
Over the past year, CPL has continued to evolve. The company’s refreshed brand is the most visible representation of that evolution, but the changes extend much deeper.
CPL continues to refine its manufacturing processes, invest in its organization, expand its expertise, and strengthen its ability to support pharmaceutical companies developing and manufacturing complex dosage forms. At CPHI Milan, CPL will have a significantly larger physical presence than in previous years, creating an opportunity for customers and prospects to get an updated picture of the company and the capabilities available to them.
For companies that know CPL primarily for one specific capability, the meeting may be particularly valuable.
CPL’s expertise extends across pharmaceutical development and commercial manufacturing for liquid and semi-solid dosage forms, including topical semi-solids, topical solutions, oral liquids, nasal products, and other specialized formulations. CPL can also provide specialized development and IVRT/IVPT capabilities through its formulation and skin laboratory expertise. The result is a development and manufacturing partner capable of supporting considerably more of a product’s journey than many companies may realize.
Bring CPL the Challenge
Some of the most productive conversations at CPHI begin with a problem.
Perhaps a promising formulation has been developed at laboratory scale and now needs a partner capable of scaling the process and manufacturing clinical trial material. A commercial product may need to be transferred because an existing manufacturing partner no longer has sufficient capacity or capabilities. A company may be looking for a second manufacturing site to strengthen business continuity. A development program may require specialized formulation expertise, analytical support, or additional testing.
In each case, the first question is essentially the same: **Can you help us?**
At CPL, the answer is likely yes.
CPL’s capabilities span the continuum from early formulation development and specialized laboratory services through scale-up, technology transfer, clinical supply, and commercial manufacturing. That breadth allows the team to look at a customer’s program as a whole rather than attempting to fit every opportunity into a narrowly defined service offering.
It also means that a conversation that begins around one immediate need can uncover opportunities to simplify the development pathway, solve downstream challenges earlier, or consolidate work with a partner capable of supporting the program as it advances.
Complex Dosage Forms Require Specialized Experience
CPL’s value becomes particularly clear when programs involve dosage forms that demand specialized formulation, process, analytical, and manufacturing expertise.
Topical creams, ointments, gels, and solutions can be highly dependent on formulation characteristics and manufacturing conditions. Oral liquids and pediatric formulations may introduce challenges involving palatability, taste masking, stability, and scale-up. Nasal products present their own combination of formulation, device, manufacturing, and commercialization considerations.
These are precisely the kinds of programs CPL wants to discuss in Milan.
The CPL team is particularly interested in conversations surrounding nasal sprays. CPL also continues to support pharmaceutical development through formulation expertise and specialized skin laboratory capabilities, including services that can help companies address increasingly complex testing and development requirements.
For generic pharmaceutical companies, development-stage organizations, and commercial Rx companies alike, CPHI provides an opportunity to bring those challenges directly to the CPL team.
Growing Opportunities in Hormone Products
Another important area of conversation in Milan will be hormone products.
CPL has established experience manufacturing testosterone products and sees growing opportunities as interest in testosterone and hormone replacement therapies continues to develop. For organizations working with testosterone gels, creams, and related products, manufacturing experience and the ability to appropriately handle these formulations can be critical considerations when evaluating a CDMO partner.
That expertise also creates a foundation for broader discussions surrounding hormone products, including estrogen- and progesterone-based formulations.
As the market evolves, CPL believes pharmaceutical companies will increasingly need partners that understand not only the formulation and manufacturing requirements associated with these products, but also the practical challenges involved in moving them efficiently from development into reliable commercial supply.
From Development Through Commercial Manufacturing
One of the most important reasons to meet CPL at CPHI Milan is the opportunity to discuss where your program is today, and where it needs to go next.
A company may arrive with a 500-gram laboratory batch that needs to become a scalable manufacturing process. Another may have an established commercial product that needs to be transferred on an aggressive timeline. Another may need a secondary manufacturing source to reduce supply-chain risk. Still another may be navigating a formulation challenge or looking for specialized laboratory capabilities to support an existing product.
Those programs may appear very different, but they share an important requirement: a partner capable of understanding the challenge and building a practical path forward.
CPL combines pharmaceutical development, scale-up, analytical and specialized laboratory capabilities, technology transfer, and commercial manufacturing within an organization experienced in complex liquid and semi-solid products. Instead of asking whether a program fits neatly into a predefined box, the CPL team begins by understanding what the customer is trying to accomplish.
Who Should Meet CPL in Milan?
CPHI Milan will be particularly valuable for pharmaceutical professionals responsible for development, manufacturing, outsourcing, technical operations, and external partnerships. That includes leaders at generic pharmaceutical companies with growing product pipelines, development-stage organizations preparing to move formulations toward clinical manufacturing, and commercial pharmaceutical companies evaluating new manufacturing capacity or secondary supply.
It is also an opportunity for senior decision-makers who may not regularly have direct access to CPL’s team in North America to meet face-to-face and explore potential programs.
Whether the need involves topical semi-solids, oral or topical liquids, nasal sprays, hormone products, formulation development, skin laboratory services, scale-up, technology transfer, or commercial manufacturing, the CPL team wants to hear about it.
Ask CPL in Milan
With tens of thousands of pharmaceutical professionals gathering at CPHI, every attendee has decisions to make about where to spend their time. If you are developing a complex dosage form, evaluating a manufacturing partner, facing a formulation or scale-up challenge, considering a technology transfer, or looking to strengthen commercial supply, make CPL part of your schedule.
Even if you already know CPL, stop by for another conversation. The company you remember may offer considerably more today than you realize.
Bring us your program. Bring us your manufacturing challenge. Bring us the question you are not sure a CDMO can answer.
Ask CPL. You may be surprised how often the answer is yes.
Visit Contract Pharmaceuticals Limited at CPHI Milan, Oct 6-8, at Stand 8F66 to meet the CPL team and discuss your next development or manufacturing program.